LPX Lipoxen

 

TIDMLPX 
 
RNS Number : 6705M 
Lipoxen PLC 
27 May 2010 
 

+---------------------------------+---------------------------------+ 
| For immediate release           |                     27 May 2010 | 
+---------------------------------+---------------------------------+ 
 
 
 
 
                                  Lipoxen plc 
                           ("Lipoxen" or the "Company") 
 
                                Director dealings 
 
The Company was informed on 27 May 2010 that FDS Pharma Associates and its 
related parties disposed of 190,266 ordinary shares of 0.5p each ("Ordinary 
Shares") at 9.78 pence each on 29 December 2009. 
 
Following these disposals FDS Pharma Associates and its related parties have an 
interest in Lipoxen of 41,965,050 Ordinary Shares, representing 24.41 per cent 
of the issued Ordinary Share capital in the Company. 
 
Enquires: 
 
+------------------------------------------+--------------------+ 
| Lipoxen plc                              |     +44 (0)20 7389 | 
|                                          |               5015 | 
+------------------------------------------+--------------------+ 
| M. Scott Maguire, Chief Executive        |                    | 
| Officer                                  |                    | 
+------------------------------------------+--------------------+ 
|                                          |                    | 
+------------------------------------------+--------------------+ 
| Singer Capital Markets (nominated        |     +44 (0)20 3205 | 
| adviser)                                 |               7500 | 
+------------------------------------------+--------------------+ 
| Jeff Keating / Claes Spång               |                    | 
+------------------------------------------+--------------------+ 
|                                          |                    | 
+------------------------------------------+--------------------+ 
| Buchanan Communications                  |     +44 (0)20 7466 | 
|                                          |               5000 | 
+------------------------------------------+--------------------+ 
| Lisa Baderoon / Catherine Breen          |                    | 
+------------------------------------------+--------------------+ 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSGMGZKDNLGGZM 
 

Lipoxen (LSE:LPX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Lipoxen (LSE:LPX)
Historical Stock Chart
From Dec 2023 to Dec 2024